These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10). Horvath R J Inherit Metab Dis; 2012 Jul; 35(4):679-87. PubMed ID: 22231380 [TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q and mitochondrial disease. Quinzii CM; Hirano M Dev Disabil Res Rev; 2010; 16(2):183-8. PubMed ID: 20818733 [TBL] [Abstract][Full Text] [Related]
17. Yeast Coq9 controls deamination of coenzyme Q intermediates that derive from para-aminobenzoic acid. He CH; Black DS; Nguyen TP; Wang C; Srinivasan C; Clarke CF Biochim Biophys Acta; 2015 Sep; 1851(9):1227-39. PubMed ID: 26008578 [TBL] [Abstract][Full Text] [Related]
18. CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Hirano M; Garone C; Quinzii CM Biochim Biophys Acta; 2012 May; 1820(5):625-31. PubMed ID: 22274133 [TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of coenzyme Q in eukaryotes. Kawamukai M Biosci Biotechnol Biochem; 2016; 80(1):23-33. PubMed ID: 26183239 [TBL] [Abstract][Full Text] [Related]
20. Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency. Yen HC; Liu YC; Kan CC; Wei HJ; Lee SH; Wei YH; Feng YH; Chen CW; Huang CC Biochim Biophys Acta; 2016 Sep; 1860(9):1864-76. PubMed ID: 27155576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]